imiquimod 37.5 MG/ML Topical Cream

What the CMS Formulary Data Shows for imiquimod 37.5 MG/ML Topical Cream

Per the CMS 2026 Part D formulary file, imiquimod 37.5 MG/ML Topical Cream (RxNorm concept RXCUI 967017, generic name imiquimod) appears on 21 distinct formulary files spanning 856 Medicare Part D plan offerings - 16.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.3.

Real-world access to imiquimod 37.5 MG/ML Topical Cream depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 4.8% require step therapy. 61.9% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 124,101 Part D beneficiaries filled imiquimod 37.5 MG/ML Topical Cream in 2023, with total plan-and-beneficiary spending of $8,603,449 and an average per-beneficiary annual cost of $69.33. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry imiquimod 37.5 MG/ML Topical Cream today.